Health In Tech, Stock Net Income
| HIT Stock | 1.07 0.07 6.14% |
Health In's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Health Stock price.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 670.5 K | 1.2 M | |
| Net Income | 670.5 K | 637 K | |
| Net Income Per Share | 0.01 | 0.02 | |
| Net Income Per E B T | 0.75 | 0.50 |
Health In Tech, Company Net Income Analysis
Health In's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Health In Net Income | 670.48 K |
Most of Health In's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health In Tech, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Health Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Health In is extremely important. It helps to project a fair market value of Health Stock properly, considering its historical fundamentals such as Net Income. Since Health In's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Health In's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Health In's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Health Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Health In Tech, reported net income of 670.48 K. This is 99.88% lower than that of the Insurance sector and 99.45% lower than that of the Financials industry. The net income for all United States stocks is 99.88% higher than that of the company.
Health Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health In's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Health In could also be used in its relative valuation, which is a method of valuing Health In by comparing valuation metrics of similar companies.Health In is currently under evaluation in net income category among its peers.
Health Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0533 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 57.01 M | ||||
| Shares Outstanding | 45.21 M | ||||
| Shares Owned By Insiders | 69.60 % | ||||
| Shares Owned By Institutions | 2.58 % | ||||
| Number Of Shares Shorted | 427.5 K | ||||
| Price To Earning | 24.13 X | ||||
| Price To Book | 3.78 X | ||||
| Price To Sales | 2.11 X | ||||
| Revenue | 19.49 M | ||||
| Gross Profit | 20.61 M | ||||
| EBITDA | 1.93 M | ||||
| Net Income | 670.48 K | ||||
| Cash And Equivalents | 7.05 B | ||||
| Cash Per Share | 15.61 X | ||||
| Total Debt | 206.69 K | ||||
| Debt To Equity | 1.14 % | ||||
| Current Ratio | 1.17 X | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | 2.18 M | ||||
| Short Ratio | 0.93 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 73 | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 64.88 M | ||||
| Total Asset | 15.77 M | ||||
| Retained Earnings | 3.94 M | ||||
| Working Capital | 8.65 M | ||||
| Current Asset | 59.12 B | ||||
| Current Liabilities | 49.33 B | ||||
| Net Asset | 15.77 M |
About Health In Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health In Tech,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health In using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health In Tech, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.